Ultragenyx Pharmaceutical (RARE) Net Cash Flow Growth (1y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 198.34% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 467.41% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -14,223.53% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 453.08% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -125.22% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 53.46% |
| 10 | Ultragenyx Pharmaceutical | 2.29 Bn | 1.89 Bn | 106.00 Mn | -436.61% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -436.61% |
| Dec 31, 2025 | 749.94% |
| Sep 30, 2025 | 107.78% |
| Jun 30, 2025 | -87.53% |
| Mar 31, 2025 | 52.42% |
| Dec 31, 2024 | -81.25% |
| Sep 30, 2024 | -1,068.89% |
| Jun 30, 2024 | 2,164.18% |
| Mar 31, 2024 | -108.17% |
| Dec 31, 2023 | 153.59% |
| Sep 30, 2023 | -112.08% |
| Jun 30, 2023 | 110.08% |
| Mar 31, 2023 | 69.80% |
| Dec 31, 2022 | -358.92% |
| Sep 30, 2022 | 352.72% |
| Jun 30, 2022 | 108.24% |
| Mar 31, 2022 | 53.43% |
| Dec 31, 2021 | -80.87% |
| Sep 30, 2021 | 33.00% |
| Jun 30, 2021 | -353.83% |
| Mar 31, 2021 | -144.41% |
| Dec 31, 2020 | 69.04% |
| Sep 30, 2020 | -1,572.18% |
| Jun 30, 2020 | 126.80% |
| Mar 31, 2020 | -185.96% |
| Dec 31, 2019 | 937.30% |
| Sep 30, 2019 | 70.32% |
| Jun 30, 2019 | -20.15% |
| Mar 31, 2019 | 24.41% |
| Dec 31, 2018 | -25.14% |
| Sep 30, 2018 | 9.54% |
| Jun 30, 2018 | -68.16% |
| Mar 31, 2018 | 4,508.72% |
| Dec 31, 2017 | 98.97% |
| Sep 30, 2017 | -135.40% |
| Jun 30, 2017 | -335.66% |
| Mar 31, 2017 | 87.48% |
| Dec 31, 2016 | 127.50% |
| Sep 30, 2016 | -23.72% |
| Jun 30, 2016 | 87.51% |
| Mar 31, 2016 | -114.84% |
| Dec 31, 2015 | -151.58% |
| Sep 30, 2015 | 218.17% |
| Jun 30, 2015 | -230.80% |
| Mar 31, 2015 | 220.11% |
| Dec 31, 2014 | -2,209.07% |
| Sep 30, 2014 | 581.83% |
| Jun 30, 2014 | 25.92% |
| Mar 31, 2014 | 324.48% |